FDA Orange Book · active-ingredient family
Iothalamate sodium
Iothalamate sodium is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ANGIO-CONRAY · NDA 013319
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ANGIO-CONRAY | MALLINCKRODT | NDA 013319 | — | Approved Prior to Jan 1, 1982 | |
| CONRAY 325 | MALLINCKRODT | NDA 017685 | — | Approved Prior to Jan 1, 1982 | |
| CONRAY 400 | MALLINCKRODT | NDA 014295 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Iothalamate sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

